Active Ingredient(s): Lenalidomide
FDA Approved: * December 27, 2005
Pharm Company: * CELGENE
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Revlimid Overview

Lenalidomide (trade name Revlimid) is a derivative of thalidomide approved in the United States in 2005.[1] It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS). Along with several other drugs developed in recent years, lenalidomide has significantly improved overall survival in myeloma (whi...

Read more Revlimid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Revlimid Forums: RSS Feed

Loss of taste

I was diagnosed with Myeloma and AL Amyloidosis in May 2016. After taking a lot of medication for 7 months, fortunately my condition went into remission and I was taken off all drugs which included Revlimid in December 2016. I am now 10 months into remission but I have lost the taste of food. Although it has improved slightly it is still there. When will it come back. Has anyone experienced a similar problem. LH ## Still have the loss of taste. Anyone experienced this and what to do!


Possible Dosages for this and Related Drugs:

  • Capsule: 10mg, 15mg, 2.5mg, 20mg, 25mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Revlimid: (6 results)

Sorted by National Drug Code
  • 59572-402 Revlimid 2.5 mg Oral Capsule by Celgene Corporation
  • 59572-405 Revlimid 5 mg Oral Capsule by Celgene Corporation
  • 59572-410 Revlimid 10 mg Oral Capsule by Celgene Corporation
  • 59572-415 Revlimid 15 mg Oral Capsule by Celgene Corporation
  • 59572-420 Revlimid 20 mg Oral Capsule by Celgene Corporation
  • 59572-425 Revlimid 25 mg Oral Capsule by Celgene Corporation

Other drugs which contain Lenalidomide or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA